BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3012860)

  • 1. Cellular differentiation and prognosis in embryonal rhabdomyosarcoma. A report from the Cooperative Soft Tissue Sarcoma Study 1981 (CWS 81).
    Schmidt D; Reimann O; Treuner J; Harms D
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):183-94. PubMed ID: 3012860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhabdomyosarcoma: morphology and cellular differentiation].
    Schmidt D; Harms D; Reimann O; Treuner J
    Klin Padiatr; 1986; 198(3):202-7. PubMed ID: 3523025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunocytochemical diagnosis of embryonal rhabdomyosarcoma of the orbit].
    Holbach L; Beck JD; Ruprecht KW; Meythaler FH
    Klin Monbl Augenheilkd; 1989 Sep; 195(3):190-5. PubMed ID: 2681959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis.
    Coffin CM; Rulon J; Smith L; Bruggers C; White FV
    Mod Pathol; 1997 Dec; 10(12):1175-87. PubMed ID: 9436961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital rhabdomyosarcoma. Immunohistochemical studies of seven cases.
    Sun XL; Zheng BH; Li B; Li LQ; Soejima K; Kanda M
    Chin Med J (Engl); 1990 Jun; 103(6):485-8. PubMed ID: 2119961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubular aggregates within the rough endoplasmic reticulum of embryonal rhabdomyosarcoma cells: a case report.
    Tsuchida R; Ishida T; Uozaki H; Bessho F; Machinami R
    Ultrastruct Pathol; 1999; 23(3):193-8. PubMed ID: 10445287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
    Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
    J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.
    Seidal T; Kindblom LG; Angervall L
    Appl Pathol; 1987; 5(4):201-19. PubMed ID: 3689591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative observation of morphology and immunohistochemistry in rhabdomyosarcoma and fetal skeletal muscle].
    Lai RQ
    Zhonghua Bing Li Xue Za Zhi; 1993 Oct; 22(5):265-8. PubMed ID: 8168190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of desmin and myoglobin in rhabdomyosarcomas and in developing skeletal muscle.
    Carter RL; McCarthy KP; Machin LG; Jameson CF; Philp ER; Pinkerton CR
    Histopathology; 1989 Dec; 15(6):585-95. PubMed ID: 2558065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal and muscle-specific intermediate filaments (vimentin and desmin) in relation to differentiation in childhood rhabdomyosarcomas.
    Molenaar WM; Oosterhuis JW; Oosterhuis AM; Ramaekers FC
    Hum Pathol; 1985 Aug; 16(8):838-43. PubMed ID: 4018780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
    Furlong MA; Fanburg-Smith JC
    Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
    Zhu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An immunohistochemical study of myoglobin and S-100 protein in rhabdomyosarcoma].
    Takebayashi K; Nojima T; Inoue K
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):690-5. PubMed ID: 3536701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma in childhood. An immunohistological analysis with myoglobin, desmin and vimentin.
    Kodet R
    Pathol Res Pract; 1989 Aug; 185(2):207-13. PubMed ID: 2798221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
    Yu L; Wang J
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative phenotypes in rhabdomyosarcomas and developing skeletal muscle.
    Carter RL; Jameson CF; Philp ER; Pinkerton CR
    Histopathology; 1990 Oct; 17(4):301-9. PubMed ID: 2258169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma.
    Cavazzana AO; Schmidt D; Ninfo V; Harms D; Tollot M; Carli M; Treuner J; Betto R; Salviati G
    Am J Surg Pathol; 1992 Mar; 16(3):229-35. PubMed ID: 1599014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy associated differentiation in rhabdomyosarcomas.
    d'Amore ES; Tollot M; Stracca-Pansa V; Menegon A; Meli S; Carli M; Ninfo V
    Mod Pathol; 1994 Jan; 7(1):69-75. PubMed ID: 8159655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonal rhabdomyosarcoma: immunohistochemical characterization.
    Geiger S; Czernobilsky B; Marshak G; Geiger B
    Oral Surg Oral Med Oral Pathol; 1985 Nov; 60(5):517-23. PubMed ID: 2414709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.